Sign In
Buy DOC
$21.65
+0.0800 (+0.371%)
At Close: Jul 10, 2026
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2026
04:15pm, Thursday, 09'th Jul 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on July 9
3 REITs to Buy for Passive Income in July
09:15am, Friday, 03'rd Jul 2026
Income investors entering July 2026 are getting a friendlier setup than they had six months ago.
Healthpeak Properties Gains 28% in 3 Months: Will the Trend Last?
03:32pm, Friday, 26'th Jun 2026
DOC surges 28% in three months as leasing, occupancy gains and Janus Living growth support its shift toward labs and outpatient assets.
5 High-Yielding S&P 500 Stocks Trading at Double-Digit Discounts Are Incredible Strong Buys Now
08:17am, Wednesday, 24'th Jun 2026
The Standard and Poor's 500 is a stock market index that tracks the performance of the 500 biggest companies in the United States. It is considered a top indicator of the U.S. stock market's health. I
Healthpeak Properties: This 6% Yielding REIT Has More Room To Run
09:00am, Friday, 19'th Jun 2026
Healthpeak Properties remains a Strong Buy, combining value, income, and recovery potential in healthcare real estate. DOC's outpatient medical and life sciences segments show improving occupancy, str
Healthpeak Properties Publishes Its 15th Annual Corporate Impact Report
04:15pm, Thursday, 18'th Jun 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. ("Healthpeak") (NYSE: DOC) announced today the release of its 15th annual 2025 Corporate Impact Report (the "Report"). The Report highlights Health
Healthpeak Properties Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast
04:15pm, Monday, 15'th Jun 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report second quarter 2
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner
11:38pm, Sunday, 07'th Jun 2026
Healthpeak Properties offers a diversified, growth-oriented REIT portfolio with 40% life science exposure and robust 2026 FFO guidance of $1.71–$1.75 per share. DOC maintains conservative 37.3% leve
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound?
12:36pm, Thursday, 04'th Jun 2026
Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?
EU clears Arla's DMK, DOC buyout, citing no competition concerns
12:54pm, Thursday, 28'th May 2026
The European Union on Thursday approved Arla Foods' acquisition of Germany's DMK and Dutch cooperative DOC without conditions, saying the deal would not harm competition in the Eu
Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?
02:41pm, Tuesday, 26'th May 2026
DOC gains 22.7% year-to-date, driven by leasing momentum, rising occupancy and Janus Living growth.
This Healthcare REIT Stands Out With 6.3% Yield
08:00am, Thursday, 14'th May 2026
With a 6.3% yield, REIT stock HealthPeak Properties is among the highest-paying players in the S&P 500, well above the current 1% average.
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns
04:32am, Thursday, 14'th May 2026
Healthpeak Properties earns a buy rating, driven by strong capital allocation and a compelling portfolio mix across Outpatient Medical, Labs, and Senior Housing. DOC trades at ~11x P/FFO with a >6% di
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity
10:45pm, Tuesday, 12'th May 2026
Healthpeak Properties is still a Buy after the recent rally, supported by strong earnings, a robust dividend, and significant re-rating potential. DOC's Q1 2026 beat on FFO and revenue; completed the
Pre-Market Stock Futures: Futures are trading mixed as we get set to start the new trading week, as reports indicate that President Trump declined Iran's counteroffer for peace. This comes after a rem
